Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ RPS15 Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA562977
Description
Immunogen sequence: MAEVEQKKKR TFRKFTYRGV DLDQLLDMSY EQLMQLYSAR QRRRLNRGLR RKQH Highest antigen sequence identity to the following orthologs: Mouse - 100%, Rat - 100%.
Ribosomes, the organelles that catalyze protein synthesis, consist of a small 40S subunit and a large 60S subunit. Together these subunits are composed of 4 RNA species and approximately 80 structurally distinct proteins. This gene encodes a ribosomal protein that is a component of the 40S subunit. The protein belongs to the S19P family of ribosomal proteins. It is located in the cytoplasm. This gene has been found to be activated in various tumors, such as insulinomas, esophageal cancers, and colon cancers. As is typical for genes encoding ribosomal proteins, there are multiple processed pseudogenes of this gene dispersed through the genome. Alternative splicing results in multiple transcript variants.
Specifications
RPS15 | |
Polyclonal | |
Unconjugated | |
RPS15 | |
40S ribosomal protein S15; homolog of rat insulinoma; insulinoma; insulinoma protein; ribosomal protein S15; rig; RIG protein; RPS15; S15; Small ribosomal subunit protein uS19 | |
Rabbit | |
Antigen Affinity Chromatography | |
RUO | |
6209 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Immunohistochemistry (Paraffin), Western Blot, Immunocytochemistry | |
0.1 mg/mL | |
PBS with 40% glycerol and 0.02% sodium azide; pH 7.2 | |
P62841 | |
RPS15 | |
Recombinant protein corresponding to Human RPS15. Recombinant protein control fragment (Product #RP-101216). | |
100 μL | |
Primary | |
Human | |
Antibody | |
IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction